Skip to content

Montelukast Sodium EP Impurity A

Montelukast Sodium EP Impurity A

Product Description
CAT No.
ALN-M031021
CAS No.
190078-45-6
Mol. F.
C35H35ClNNaO3S
Mol. Wt.
608.2
Stock
Please Inquire
RFQ
Chemical Name : Sodium 1-[[[(1S)-1-[3-[(1E)-2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]sulfanyl]methyl]cyclopropyl]acetate (as per EP);
Smiles : CC(C1=CC=CC=C1CC[C@H](SCC2(CC2)CC(O[Na])=O)C3=CC=CC(/C=C/C4=NC5=CC(Cl)=CC=C5C=C4)=C3)(C)O
Inchi : InChI=1S/C14H22O4S2/c1-17-11(15)7-13(3-4-13)9-19-20-10-14(5-6-14)8-12(16)18-2/h3-10H2,1-2H3
Synonym : (S)-Montelukast

Method development and validation for the simultaneous estimation of montelukast and acebrophylline in bulk and tablet dosage forms by RP-HPLC

By Ankitha, M.; Ashitha, S.; Sri, Ragasudha A.; Latha, Madhavi P. V.; Devi, Uma P.nFrom Journal of Global Trends in Pharmaceutical Sciences (2021), 12(1), 9173-9179

Montelukast microsuspension with hypromellose for improved stability and oral absorption

By Lee, Ha Ryeong; Park, Hyun Jin; Park, Jun Soo; Park, Dong Woo; Ho, Myoung Jin; Kim, Dong Yoon; Lee, Hyo Chun; Kim, Eun Jeong; Song, Woo Heon; Park, Jun Sang; et al – From International Journal of Biological Macromolecules (2021), 183, 1732-1742

Analytical method development and validation for simultaneous estimation of Bilastine and Montelukast sodium by UV spectrophotometry

By Raj, R. Mohan; Sankar, A. S. K.; Vetrichelvan, T. – From World Journal of Pharmacy and Pharmaceutical Sciences (2021), 10(1), 680-687

Request For Quotation